Titre : Troubles de stress post-traumatique

Troubles de stress post-traumatique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Profiling
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Troubles de stress post-traumatique : Questions médicales les plus fréquentes", "headline": "Troubles de stress post-traumatique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Troubles de stress post-traumatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-11", "dateModified": "2025-04-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Troubles de stress post-traumatique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles de stress traumatique", "url": "https://questionsmedicales.fr/mesh/D040921", "about": { "@type": "MedicalCondition", "name": "Troubles de stress traumatique", "code": { "@type": "MedicalCode", "code": "D040921", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.950.750" } } }, "about": { "@type": "MedicalCondition", "name": "Troubles de stress post-traumatique", "alternateName": "Stress Disorders, Post-Traumatic", "code": { "@type": "MedicalCode", "code": "D013313", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "John H Krystal", "url": "https://questionsmedicales.fr/author/John%20H%20Krystal", "affiliation": { "@type": "Organization", "name": "Clinical Neurosciences Division, United States Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, West Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, 300 George Street #901, New Haven, CT 06511, USA. Electronic address: john.krystal@yale.edu." } }, { "@type": "Person", "name": "Claudia Carmassi", "url": "https://questionsmedicales.fr/author/Claudia%20Carmassi", "affiliation": { "@type": "Organization", "name": "Psychiatric Clinic, Department of Clinical and Experimental Medicine, University of Pisa, Italy." } }, { "@type": "Person", "name": "Liliana Dell'Osso", "url": "https://questionsmedicales.fr/author/Liliana%20Dell%27Osso", "affiliation": { "@type": "Organization", "name": "Psychiatric Clinic, Department of Clinical and Experimental Medicine, University of Pisa, Italy." } }, { "@type": "Person", "name": "Jonathan I Bisson", "url": "https://questionsmedicales.fr/author/Jonathan%20I%20Bisson", "affiliation": { "@type": "Organization", "name": "Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, United Kingdom. Electronic address: bissonji@cardiff.ac.uk." } }, { "@type": "Person", "name": "Ilan Harpaz-Rotem", "url": "https://questionsmedicales.fr/author/Ilan%20Harpaz-Rotem", "affiliation": { "@type": "Organization", "name": "Clinical Neurosciences Division, United States Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, West Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, 300 George Street #901, New Haven, CT 06511, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Genome-wide identification and expression profiling of sugar transporter genes in tobacco.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/35714802", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gene.2022.146652" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37533202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.6411" } }, { "@type": "ScholarlyArticle", "name": "The NeuroinflammatoryPotential of HIV-1 NefVariants in Modulating the Gene Expression Profile of Astrocytes.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36291123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cells11203256" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/35771282", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00401-022-02460-1" } }, { "@type": "ScholarlyArticle", "name": "Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.", "datePublished": "2024-09-24", "url": "https://questionsmedicales.fr/article/39317454", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/rmdopen-2024-004600" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Troubles mentaux", "item": "https://questionsmedicales.fr/mesh/D001523" }, { "@type": "ListItem", "position": 3, "name": "Troubles liés aux traumatismes et au stress", "item": "https://questionsmedicales.fr/mesh/D000068099" }, { "@type": "ListItem", "position": 4, "name": "Troubles de stress traumatique", "item": "https://questionsmedicales.fr/mesh/D040921" }, { "@type": "ListItem", "position": 5, "name": "Troubles de stress post-traumatique", "item": "https://questionsmedicales.fr/mesh/D013313" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Troubles de stress post-traumatique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Troubles de stress post-traumatique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Troubles de stress post-traumatique", "description": "Comment diagnostique-t-on le TSPT ?\nQuels critères sont utilisés pour le TSPT ?\nQui peut diagnostiquer le TSPT ?\nLe TSPT peut-il être confondu avec d'autres troubles ?\nQuels tests sont utilisés pour le TSPT ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Gene+Expression+Profiling&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Troubles de stress post-traumatique", "description": "Quels sont les symptômes principaux du TSPT ?\nLe TSPT cause-t-il des problèmes de sommeil ?\nY a-t-il des symptômes émotionnels associés ?\nLe TSPT entraîne-t-il des problèmes de concentration ?\nLes symptômes du TSPT sont-ils constants ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Gene+Expression+Profiling&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Troubles de stress post-traumatique", "description": "Peut-on prévenir le TSPT après un traumatisme ?\nQuels facteurs de protection existent contre le TSPT ?\nLes programmes de sensibilisation aident-ils ?\nLe soutien familial est-il important ?\nLes techniques de gestion du stress aident-elles ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Gene+Expression+Profiling&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Troubles de stress post-traumatique", "description": "Quels traitements sont efficaces pour le TSPT ?\nLes médicaments sont-ils utilisés pour le TSPT ?\nLa thérapie de groupe est-elle bénéfique ?\nLe TSPT peut-il être traité par des approches alternatives ?\nCombien de temps dure le traitement du TSPT ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Gene+Expression+Profiling&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Troubles de stress post-traumatique", "description": "Quelles complications peuvent survenir avec le TSPT ?\nLe TSPT augmente-t-il le risque de suicide ?\nLe TSPT peut-il affecter la santé physique ?\nLes troubles de l'usage de substances sont-ils fréquents ?\nLe TSPT peut-il affecter la vie professionnelle ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Gene+Expression+Profiling&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Troubles de stress post-traumatique", "description": "Quels sont les facteurs de risque du TSPT ?\nLe sexe influence-t-il le risque de TSPT ?\nL'âge joue-t-il un rôle dans le TSPT ?\nUn antécédent de troubles mentaux augmente-t-il le risque ?\nLes événements traumatiques répétés augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Gene+Expression+Profiling&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on le TSPT ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation des symptômes et l'historique du patient." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le TSPT ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent l'exposition à un traumatisme et des symptômes persistants." } }, { "@type": "Question", "name": "Qui peut diagnostiquer le TSPT ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un professionnel de santé mentale, comme un psychiatre ou un psychologue, peut diagnostiquer." } }, { "@type": "Question", "name": "Le TSPT peut-il être confondu avec d'autres troubles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec l'anxiété ou la dépression, nécessitant une évaluation approfondie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le TSPT ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de tests spécifiques, mais des questionnaires d'évaluation peuvent être utilisés." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux du TSPT ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des flashbacks, des cauchemars, et une hypervigilance." } }, { "@type": "Question", "name": "Le TSPT cause-t-il des problèmes de sommeil ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de TSPT peuvent souffrir d'insomnie ou de cauchemars fréquents." } }, { "@type": "Question", "name": "Y a-t-il des symptômes émotionnels associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des sentiments de colère, de tristesse ou de détachement émotionnel peuvent survenir." } }, { "@type": "Question", "name": "Le TSPT entraîne-t-il des problèmes de concentration ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes peuvent éprouver des difficultés de concentration et de mémoire." } }, { "@type": "Question", "name": "Les symptômes du TSPT sont-ils constants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils peuvent fluctuer en intensité et être déclenchés par des rappels du traumatisme." } }, { "@type": "Question", "name": "Peut-on prévenir le TSPT après un traumatisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des interventions précoces, comme le soutien psychologique, peuvent réduire le risque de TSPT." } }, { "@type": "Question", "name": "Quels facteurs de protection existent contre le TSPT ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un bon réseau de soutien social et des stratégies de coping efficaces peuvent aider." } }, { "@type": "Question", "name": "Les programmes de sensibilisation aident-ils ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les programmes de sensibilisation peuvent informer sur le TSPT et ses traitements." } }, { "@type": "Question", "name": "Le soutien familial est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien familial peut jouer un rôle crucial dans la prévention et la récupération." } }, { "@type": "Question", "name": "Les techniques de gestion du stress aident-elles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme la méditation et le yoga peuvent réduire le stress post-traumatique." } }, { "@type": "Question", "name": "Quels traitements sont efficaces pour le TSPT ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie cognitivo-comportementale et les médicaments." } }, { "@type": "Question", "name": "Les médicaments sont-ils utilisés pour le TSPT ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antidépresseurs et anxiolytiques peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "La thérapie de groupe est-elle bénéfique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie de groupe peut offrir un soutien et des stratégies de coping aux patients." } }, { "@type": "Question", "name": "Le TSPT peut-il être traité par des approches alternatives ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines approches comme la méditation et l'art-thérapie peuvent aider à gérer les symptômes." } }, { "@type": "Question", "name": "Combien de temps dure le traitement du TSPT ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie, mais peut durer plusieurs mois à plusieurs années selon les cas." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le TSPT ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent la dépression, l'anxiété, et des problèmes relationnels." } }, { "@type": "Question", "name": "Le TSPT augmente-t-il le risque de suicide ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de TSPT ont un risque accru de pensées suicidaires et de tentatives." } }, { "@type": "Question", "name": "Le TSPT peut-il affecter la santé physique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le TSPT peut entraîner des problèmes de santé physique comme des douleurs chroniques." } }, { "@type": "Question", "name": "Les troubles de l'usage de substances sont-ils fréquents ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses personnes atteintes de TSPT développent des troubles liés à l'usage de substances." } }, { "@type": "Question", "name": "Le TSPT peut-il affecter la vie professionnelle ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent interférer avec la concentration et la performance au travail." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du TSPT ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition à des événements traumatiques, l'historique familial et le stress." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de TSPT ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus susceptibles de développer un TSPT après un traumatisme que les hommes." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le TSPT ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes adultes et les adolescents sont souvent plus vulnérables au TSPT." } }, { "@type": "Question", "name": "Un antécédent de troubles mentaux augmente-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un antécédent de troubles mentaux peut accroître le risque de développer un TSPT." } }, { "@type": "Question", "name": "Les événements traumatiques répétés augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes exposées à des traumatismes répétés ont un risque plus élevé de TSPT." } } ] } ] }

Sources (10000 au total)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.

Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all major cancers. Chemotherapy is the mainstay systemic therapy for PDAC, and chemoresistance is a major clinical problem leadi... Archived formalin-fixed paraffin-embedded tumor tissue samples from patients treated with neoadjuvant chemotherapy were obtained during surgical resection. Specimens were macrodissected and gene expre... Initially, unsupervised multivariate modeling was performed by principal component analysis, which demonstrated a distinct gene expression profile between good- and poor-chemotherapy responders. There... A distinct tumor biological profile between PDAC patients who either respond or not respond to chemotherapy was identified....

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

To identify differentially expressed genes in temporal artery biopsies (TABs) from patients with giant cell arteritis (GCA) with different histological patterns of inflammation: transmural inflammatio... Expression of 770 immune-related genes was profiled with the NanoString nCounter PanCancer Immune Profiling Panel on formalin-fixed paraffin-embedded TABs from 42 GCA patients with TMI, 7 GCA patients... Unsupervised clustering of the samples revealed two distinct groups: normal TABs and TABs with ILA in one group, 41/42 TABs with TMI in the other one. TABs with TMI showed 31 downregulated and 256 upr... TABs with TMI had a distinct transcriptome compared with normal TABs and TABs with ILA. The few genes potentially deregulated in ILA were also deregulated in TMI. Gene profiling allowed to deepen the ...

Identification and Validation of Common Reference Genes for Normalization of Esophageal Squamous Cell Carcinoma Gene Expression Profiles.

Esophageal squamous cell carcinoma (ESCC) is one of the subtypes of esophageal cancer with Chinese characteristics, and its five-year survival rate is less than 20%. Early diagnosis is beneficial to i...

Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis.

To investigate the relationship between primary ovarian insufficiency and autophagy, we detected and got the expression profile of human granulosa cell line SVOG, which was with or without LPS induced... Totally, 6 genes were selected as candidate hub genes which might correlate with the process of primary ovarian insufficiency. The expression of hub genes was then validated by quantitative real-time ... The results indicated that autophagy might play an essential role in the process and underlying molecular mechanism of primary ovarian insufficiency, which was revealed for the first time and may help...

Intralesional gene expression profile of JAK-STAT signaling pathway and associated cytokines in

The JAK-STAT signaling pathway is a central cascade of signal transduction for the myriad of cytokines in which dysregulation has been implicated in progression of inflammatory and infectious diseases... This study sought to investigate differential gene expression of several cytokines and their associated... Results showed that the gene expression levelsof both Th1 (... Our finding revealed dysregulation of cytokines and related...

Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells.

Gonadotrophic pituitary adenoma is a major subtype of pituitary adenoma in the sellar region, but it is rarely involved in the hypersecretion of hormones into blood; thus, it is commonly regarded as "... The hPASCs from 14 human gonadotrophic pituitary adenoma clinical samples were cultured and verified via immunohistochemistry. Genetic profiling of hPASCs and the matched tumor cells was performed thr... The hPASCs were successfully isolated and cultured from gonadotrophic pituitary adenoma in vitro, which were identified as positive for generic stem cell markers (Sox2, Oct4, Nestin and CD133) via imm... Genetic profiling of hPASCs may explain the tumorigenesis and invasiveness of gonadotrophic pituitary adenoma. ANXA2 may serve as a potential therapeutic target for the treatment of gonadotrophic pitu...